Page last updated: 2024-08-24

triazoles and nvp-bsk805

triazoles has been researched along with nvp-bsk805 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheon, JH; Kim, HS; Kim, KS; Kim, M; Yadav, DK; Yoon, S	1

Other Studies

1 other study(ies) available for triazoles and nvp-bsk805

Article	Year
The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine. Biochemical and biophysical research communications, 2017, 09-02, Volume: 490, Issue:4 Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Janus Kinase 2; Protein Kinase Inhibitors; Pyridines; Quinoxalines; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured; Vincristine	2017

Article

Year

The JAK2 inhibitors CEP-33779 and NVP-BSK805 have high P-gp inhibitory activity and sensitize drug-resistant cancer cells to vincristine.

Biochemical and biophysical research communications, 2017, 09-02, Volume: 490, Issue:4

Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Janus Kinase 2; Protein Kinase Inhibitors; Pyridines; Quinoxalines; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured; Vincristine

2017